Ryoji Kawakami

10PUBLICATIONS
36CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 01, 2026
Foxp3 drives context-dependent epigenetic programs that define regulatory T cell molecular identity and function.

|Dec 04, 2025
Prostaglandin E2-EP2/EP4 signaling induces the tumor-infiltrating Treg phenotype for tumor growth.

Ryuma Matsuura, Siwakorn Punyawatthananukool, Ryoji Kawakami

|Oct 22, 2025
Generating functionally stable and antigen-specific Treg cells from effector T cells for cell therapy of inflammatory diseases.

Norihisa Mikami, Ryoji Kawakami, Atsushi Sugimoto

|Oct 21, 2025
Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance.

Masaya Arai, Ryoji Kawakami, Yamami Nakamura

|Aug 12, 2025
Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell-related lung fibrosis by activating STAT5.

Masaya Matsuda, Yuna Fujiwara, Fumiya Yonezawa

|Apr 10, 2025
Treg cells augment self-tolerance during infection.

Ryoji Kawakami, Shimon Sakaguchi

Pageof 2

Frequent Collaborators

9 joint publications

Shimon Sakaguchi

7 joint publications

Norihisa Mikami

2 joint publications

Masaya Arai

1 joint publications

Kelvin Y Chen